These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 24428867)
1. High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension. Kim KJ; Baek IW; Park YJ; Yoon CH; Kim WU; Cho CS Int J Rheum Dis; 2015 Jun; 18(5):524-32. PubMed ID: 24428867 [TBL] [Abstract][Full Text] [Related]
3. Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study. Castillo-Martínez D; Marroquín-Fabián E; Lozada-Navarro AC; Mora-Ramírez M; Juárez M; Sánchez-Muñoz F; Vargas-Barrón J; Sandoval J; Amezcua-Guerra LM Lupus; 2016 Jan; 25(1):61-6. PubMed ID: 26306740 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Prabu A; Patel K; Yee CS; Nightingale P; Situnayake RD; Thickett DR; Townend JN; Gordon C Rheumatology (Oxford); 2009 Dec; 48(12):1506-11. PubMed ID: 19671698 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy. Ruiz-Irastorza G; Garmendia M; Villar I; Egurbide MV; Aguirre C Autoimmun Rev; 2013 Jan; 12(3):410-5. PubMed ID: 22841984 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival. Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566 [TBL] [Abstract][Full Text] [Related]
7. Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol. Álvarez Troncoso J; Soto Abánades C; Robles-Marhuenda Á; Alcolea Batres S; Fernández Velilla Peña M; Jiménez Valero S; Sorriguieta Torre R; Rios-Blanco JJ RMD Open; 2024 Jan; 10(1):. PubMed ID: 38191213 [TBL] [Abstract][Full Text] [Related]
8. Association of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus Erythematosus. Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1702-11. PubMed ID: 26018410 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with development and mortality of pulmonary hypertension in systemic lupus erythematosus patients. Kim JS; Kim D; Joo YB; Won S; Lee J; Shin J; Bae SC Lupus; 2018 Oct; 27(11):1769-1777. PubMed ID: 30028258 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors. Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850 [TBL] [Abstract][Full Text] [Related]
12. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients. Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672 [TBL] [Abstract][Full Text] [Related]
13. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Li M; Wang Q; Zhao J; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Tian Z; Liu Y; He J; Zhang F; Zhao Y; Zeng X; Lupus; 2014 Sep; 23(10):1085-91. PubMed ID: 24651670 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension in systemic lupus erythematosus. Shen JY; Chen SL; Wu YX; Tao RQ; Gu YY; Bao CD; Wang Q Rheumatol Int; 1999; 18(4):147-51. PubMed ID: 10220835 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Foïs E; Le Guern V; Dupuy A; Humbert M; Mouthon L; Guillevin L Clin Exp Rheumatol; 2010; 28(6):836-41. PubMed ID: 21205461 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry. Jeon CH; Chai JY; Seo YI; Jun JB; Koh EM; Lee SK; Int J Rheum Dis; 2012 Oct; 15(5):e80-9. PubMed ID: 23083052 [TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance? Karadag O; Calguneri M; Yavuz B; Atalar E; Akdogan A; Kalyoncu U; Kiraz S; Aksoyek S; Ozmen F; Ertenli AI Clin Rheumatol; 2007 Oct; 26(10):1701-4. PubMed ID: 17318274 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension in SLE: what do we know? Prabu A; Gordon C Lupus; 2013 Oct; 22(12):1274-85. PubMed ID: 24098000 [TBL] [Abstract][Full Text] [Related]
19. Incidence and clinical characteristics of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Yan W; Peng LY; Ban CJ; Xu XF; Zhu M; Liu Y; Zhang S; Zhai ZG; Wang C; Dai HP Chin Med J (Engl); 2015 Apr; 128(7):896-901. PubMed ID: 25836609 [TBL] [Abstract][Full Text] [Related]